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Individual members of the retinoblastoma (Rb) tumor
suppressor gene family serve critical roles in the con-
trol of cellular proliferation and differentiation, but the
extent of their contributions is masked by redundant
and compensatory mechanisms. Here we employed
a conditional knockout strategy to simultaneously
inactivate all three members, Rb, p107, and p130,
in adult hematopoietic stem cells (HSCs). Rb family
triple knockout (TKO) mice develop a cell-intrinsic
myeloproliferation that originates from hyperprolifer-
ative early hematopoietic progenitors and is accom-
panied by increased apoptosis in lymphoid progeni-
tor populations. Loss of quiescence in the TKO HSC
pool is associated with an expansion of these mutant
stem cells but also with an enhanced mobilization
and an impaired reconstitution potential upon trans-
plantation. The presence of a single p107 allele is
sufficient to largely rescue these defects. Thus, Rb
family members collectively maintain HSC quies-
cence and the balance between lymphoid and
myeloid cell fates in the hematopoietic system.
INTRODUCTION
Hematopoiesis initiates from multipotent hematopoietic stem
cells (HSCs) that normally reside in the bone marrow (BM).
HSC populations are largely quiescent but have the capacity to
proliferate and differentiate into progenitors whose amplification
ensures the constant and rapid renewal of all blood compart-
ments (Metcalf, 2007; Zon, 2008).
A number of recent studies have pointed to a role for cell-cycle
regulators and signaling pathways in the control of HSCs and
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cal role in the proliferative capacity of normal HSCs and leukemic
stem cells. Bmi-1 functions in HSCs at least partly through its re-
pressive action of the p16INK4a, p19ARF, and p21CIP1 cell-cycle in-
hibitors (Fasano et al., 2007; Oguro et al., 2006; Park et al., 2003).
These cell-cycle inhibitors and their family members generally
restrain the ability of HSCs to proliferate and mediate the re-
sponse of HSCs to stress signals (Cheng et al., 2000a, 2000b;
Janzen et al., 2006; Yuan et al., 2006). Similarly, HSCs with
mutations in cyclin-dependent kinases and their cyclin partners
display decreased proliferation (Kozar et al., 2004; Malumbres
et al., 2004). Another critical pathway that controls the self-
renewal potential and stress response of HSCs is the PTEN-
FoxO signaling module (Miyamoto et al., 2007; Tothova et al.,
2007; Yilmaz et al., 2006; Zhang et al., 2006). However, the
mechanisms by which HSCs normally maintain their quiescence
state and transiently re-enter the cell cycle to produce hemato-
poietic progenitors are still not fully understood. In addition,
the functional links between the cell-cycle machinery and the
network of transcription factors regulating the fate of hematopoi-
etic progenitors remain unclear (Orford and Scadden, 2008).
The three members of the retinoblastoma family of transcrip-
tional regulators, pRB, p107, and p130, integratemultiple cellular
signals to control cellular proliferation and differentiation (Wiken-
heiser-Brokamp, 2006). pRB family members act downstream of
many of the critical cell-cycle regulators previously studied in
HSCs. Thus, pRB family proteins are strong candidates to regu-
late HSCs and hematopoiesis. But no blood phenotype is
observed in p130 mutant mice (Cobrinik et al., 1996), and loss
of p107 results in a mild myeloid hyperplasia that is only visible
in a Balb/c genetic background (LeCouter et al., 1998). Rb defi-
ciency in mice does not provoke major blood defects except in
erythropoiesis (Chen et al., 1993; Iavarone et al., 2004; Sankaran
et al., 2008; Spike et al., 2004; Spike andMacleod, 2005;Walkley
andOrkin, 2006;Walkley et al., 2007). Given its strong cell-cycle-
inhibitory functions and broad tumor suppressor activity, loss of
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HSCs (Walkley and Orkin, 2006; Walkley et al., 2007), except
under stress conditions (Daria et al., 2008).
Activation of CyclinD/Cdk4 kinase complexes and loss of
p16Ink4a function, two upstream regulators of pRB, p107, and
p130, are common in leukemias and lymphomas (Leoncini
et al., 2006; Spike andMacleod, 2005). Based on these observa-
tions, the absence of a significant hematopoietic phenotype in
mice mutant with single Rb family genes, and the known exten-
sive functional redundancy within this gene family in many cell
types (Wikenheiser-Brokamp, 2006), we sought to inactivate
Rb, p107, and p130 in adult mouse HSCs. To this end, we em-
ployed a conditional mutant strategy that bypasses the lethality
of mutations in Rb family genes (Wikenheiser-Brokamp, 2006).
We show that pRB family proteins collectively regulate programs
of genes that normally inhibit the proliferation of HSCs and con-
trol the fate of hematopoietic progenitors. These experiments
indicate that one key mechanism by which loss of pRB family
function may initiate preneoplastic defects is by unrestricting
the proliferation of adult stem cells.
RESULTS
Compound Ablation of the Rb Gene Family in Mice
Results in a Severe Hematopoietic Phenotype
with Excessive Expansion of Myeloid Cells
Similar to recent reports (Daria et al., 2008; Walkley and Orkin,
2006; Walkley et al., 2007), we found that Rb deletion in mouse
HSCs does not significantly alter HSC functions but results
in a mild myeloid neutrophilic expansion accompanied by extra-
medullary hematopoiesis (data not shown and see Figure S1
available online). We surmised that the additional deletion of
p107 and p130 may unmask novel roles for this gene family in
the hematopoietic system. To inactivate the entire Rb gene
family in adult mouse HSCs, we generated Mx1-Cre Rblox/lox;
p130lox/lox;p107/ (Mx1-Cre condTKO) mice. Adult Mx1-Cre
condTKO mice were injected with pI-pC to activate the Cre
recombinase and delete the Rb and p130 genes in HSCs.
Real-time quantitative RT-PCR (q-RT-PCR) analysis showed
that a significant number of mutant cells are present in the BM
of induced Mx1-Cre TKO mice (Figure S2A). TKO mice died
within 1–3 months, whereas the viability of control mice was
unaffected by pI-pC injections.
Histopathological analysis of moribund Mx1-Cre TKO mice
revealed marked spleen enlargement, with a severe disruption
of the splenic architecture. A majority of splenocytes from
Mx1-Cre TKO mice exhibited an eosinophilic morphology (Fig-
ure 1A). Infiltrating leukocytes were present in the kidney, liver,
lungs, and skin (Figures 1B and data not shown). The BM struc-
ture was also altered and showed a marked expansion of
myeloid cells, particularly eosinophils (Figure 1C).
Next, we examined the distribution of the different hematopoi-
etic lineages in TKO mice. Cell counts from TKO BM cytospins
showed a decrease in the percentage of lymphocytes and
neutrophils, accompanied by an increase in the frequency ofmy-
eloid precursors and mature eosinophils (2% in controls versus
20% in mutants) (Figure 1D). FACS analysis for myeloid markers
indicated that the BM fromMx1-Cre TKO contained a large pop-
ulation of cells positive for Mac-1 and expressing low levels ofGr-1 (which we refer to as pre-M population) (Figures 1E and
1F). Cytospins from sorted BM subpopulations showed high
heterogeneity in the pre-M population and well-differentiated
granulocytes in the Mac-1+, Gr-1high population, as expected
(Figure S2B). In addition, decreased percentages of Mac-1+,
Gr-1high granulocytes (Figures 1E and 1F), erythrocytes, and B
lymphocytes (Figure 1F and Figure S2C) were counted in the
BM of mutant mice. While the pre-M myeloid expansion was re-
stricted to the BMofMx1-Cre TKOmice at early time points (data
not shown), sick mice displayed extramedullary hematopoiesis.
FACS analysis of splenocytes showed an increase in the number
of pre-M cells (Figure 1G and Figure S2D). In addition, we
observed an increase in the number of splenic erythrocytes at
various stages of differentiation (Figure S2D, middle panel, and
Figure S3). The total number of B cells in the spleen of TKO
mice was not altered compared to control mice (Figure 1G, right,
and Figure S2D).
These observations indicate that deletion of Rb, p107, and
p130 inMx1-Cre TKOmice induces the development of amyelo-
proliferation characterized by the rapid expansion of a population
of Mac-1+, Gr-1low (pre-M) myeloid cells with eosinophilic histo-
logical features. This disease originates from the BM, does not
involve the peripheral blood (PB) (data not shown) but spreads
to other organs, and is accompanied by general perturbations
in the hematopoiesis of the mutant mice.
Early Hematopoietic Progenitors and Stem Cells Are
Actively Cycling and More Numerous in TKO Mice
The expansion of pre-M cells in TKO mice could originate from
an increase in the proliferative capacity of these cells or of mye-
loid progenitor (MP) cells. However, cell-cycle analysis of pre-M
and MP cells isolated from TKO and control mice did not reveal
any significant differences in their cell-cycle profiles (Figure 2A).
This result led us to analyze the cell cycle of early hematopoietic
progenitors of the KLS compartment (c-Kit+, negative for lineage
markers of differentiation, and Sca1+); KLS cells include HSCs
and multipotent progenitors (MPPs). Strikingly, we found that
TKO KLS cells were significantly more proliferative than control
KLS cells (Figure 2A, right). We also observed a significant
increase in the number of KLS and MP cells in the BM of sick
Mx1-Cre TKO mice. Within the KLS population, both Flk2+ cells
(MPP) and Flk2 cells (ST-HSC and LT-HSC) were increased
(Figures 2B and 2C). Within theMP population, commonmyeloid
progenitor (CMP, FcgR+) and megakaryocyte-erythrocyte pro-
genitor (MEP, FcgR) numbers were decreased in Mx1-Cre
TKO mice, while granulocyte-monocyte progenitor (GMP,
FcgRhigh) numbers were increased (Figures 2B and 2D). In the
lymphoid lineage, the number of common lymphoid progenitor
(CLP) cells was significantly decreased in Mx1-Cre TKO mice
compared to controls (Figures 2E and 2F), and Annexin V stain-
ing experiments showed significantly higher numbers of apopto-
tic CLP in mutant mice (data not shown, see below).
Based on these observations, we further tested the cell-cycle
profile of subpopulations of stem/progenitors cells. Within the
KLS population, both CD34+ (MPP and ST-HSC) and CD34
(LT-HSC) displayed enhanced proliferation (Figure 2G). This
increased proliferation was not associated with changes in the
apoptotic rates of these cells (data not shown). CMP cells, while
decreased in numbers, cycled more rapidly, while GMP cells,Cell Stem Cell 3, 416–428, October 9, 2008 ª2008 Elsevier Inc. 417
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Rb Family Inactivation in Hematopoietic Stem CellsFigure 1. Mx1-Cre TKO Mice Develop a Pathological Myeloid Eosinophilic Expansion
(A) Spleen defects in Mx1-Cre TKO mice. (Top) The spleen of two TKO mice (right) is enlarged compared to that of a control (CT) animal (left). (Middle) The
architecture of TKO mutant spleens is altered compared to control spleens in H&E sections, with an expansion of myeloid-like cells (arrow) (magnification
2003). (Bottom) Cytospins of splenocytes from control or Mx1-Cre TKO. Arrows show eosinophils (6303).
(B) Myeloid cells infiltrate the kidney, liver, and lung of TKO mice (arrows) (2003).
(C) BM defects in TKOmice. The architecture of the BM is altered in TKOmice compared to control animals (4003), and cytospins of unfractioned BM cells show
an expansion of eosinophilic granulocytes in TKO mice (arrow) (6303).
(D) Proportion of the different hematopoietic lineages in cytospins from the BMof control andMx1-Cre TKOmice (n = 5), 2months after pI-pC treatment.B, blasts;
MM, maturing myelomonocytes; N, neutrophils; Eo, eosinophils; M, monocytes; L, lymphocytes; Er, erythroid cells.
(E) FACS analysis of myeloid cells (Mac-1/Gr-1) in the BM of control and TKO mice.
(F) Cellularity of mature populations in the BM (four limbs) (n = 5).
(G) Cellularity of mature populations in the spleen (n = 5). Data are mean ± SD.which are more numerous in TKO mice, did not cycle more
(Figure 2G).
We next performed methylcellulose cultures using unfrac-
tioned BM cells and sorted KLS, MP, and pre-M cells. Unfrac-
tioned BM cells from Mx1-Cre TKO mice displayed a reduced
number of colonies compared to controls (Figure 2H); this
decrease is likely due to the dilution of the cells that have the ca-
pacity to form colonies by expanding pre-M cells. Nevertheless,
the relative number of TKO granulocytic colonies (G-CFU) was
increased compared to control cells, while the number of mixed
colonies (GEMM-CFU) was decreased, which suggests a differ-
entiation bias toward the granulocytic myeloid lineage. Purified
Mx1-Cre TKO KLS cells produced a higher number of colonies
418 Cell Stem Cell 3, 416–428, October 9, 2008 ª2008 Elsevier Inc.compared to control cells, with again an increase in G-CFU
and a decrease in GEMM-CFU. We observed a similar trend
toward G-CFU with sorted MP populations. Only colonies ob-
tained fromKLS cells, but not MP cells, could be serially replated
(data not shown). In addition, we did not observe colony forma-
tion from the more mature TKO pre-M cells, confirming that
thesemutant cells had not acquired a significant proliferation po-
tential (data not shown). Together, these data suggest that the
disease observed in TKO mice may result from the abnormal
proliferation of early hematopoietic progenitors in the KLS and
CMP compartments as well as from a change in the fate of these
progenitors toward themyeloid lineage, and not by the increased
proliferation potential of more mature myeloid cell populations.
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the TKO Myeloproliferation
To assess the importance of the simultaneous inactivation of the
threeRb familymembers for these phenotypes, we genetically re-
introduced one wild-type allele of p107 and analyzed the BM of
these p107-Single mice (Mx1-Cre Rblox/lox;p130lox/lox;p107+/).
As expected, p107-Single mice developed splenomegaly indica-
tive of extramedullary hematopoiesis (data not shown). Strikingly,
however, the BM of p107-Single mice did not exhibit a myelopro-
liferation (Figure 3A). p107-Single mice had similar numbers of
KLS,MP, andpre-Mcells in theBMascontrolmiceasdetermined
by FACS analysis (Figures 3B and 3C) and no increase in pre-M
cells in the spleen (Figure 3D). The cell cycle of KLS cells was
also similar in control and p107-Single mice (Figure 3E). The ab-
sence of a myeloproliferative phenotype illustrates the extent of
the functional overlap within the Rb gene family and the necessity
to inactivateall threegenes toseverelydisruptearlyhematopoietic
development. Interestingly, however, the decrease in the number
of lymphoid cells (both CLP and B cell populations) observed in
TKO mice is still present in p107-Single mice (Figures 3B–3D),
suggesting that different cell types during hematopoiesis may be
differentially sensitive to different levels of Rb family function.
TKO HSCs Display Increased Mobilization and Are
Incapable of Long-Term Reconstitution of the
Hematopoietic System
The hyperproliferative phenotype of TKO KLS populations led us
to further investigate the properties of these mutant stem cells.
Since increased proliferation of hematopoietic progenitor cells
is associated with their increased mobilization (Passegue et al.,
2005), we examined the mobilization of TKO hematopoietic pro-
genitors. The spleen ofMx1-Cre TKO mice contained increased
numbers of HSC and progenitor populations, indicative of extra-
medullary hematopoiesis (Figures 4A–4C). This was confirmed
by the increase in the number of colonies formed by unfractioned
splenocytes in methylcellulose (Figure 4D). Overall, there were
approximately four times more Flk2 HSCs in the spleen of
mutant mice compared to their BM (compare Figures 4C and
2C). KLS and MP cells were also more frequent in the PB of
mutant mice (Figure 4E), providing further evidence of their
increased mobilization.
To test the homing capacity of TKO progenitors, lineage-neg-
ative cells, enriched in hematopoietic progenitors, were labeled
with the fluorescent vital dye CFSE and transplanted into suble-
thally irradiated SCID mice. Under these conditions, fewer
CFSE-labeled cells from Mx1-Cre TKO mice homed to the BM
of the recipient mice (n = 10) (Figure 4F). Together, these data
indicate that hyperproliferative TKO hematopoietic progenitors
are constitutively mobilized and display a decreased homing
capacity.
The long-term engraftment potential of hematopoietic cells
resides predominantly in the quiescent pool of HSCs (Fleming
et al., 1993; Passegue et al., 2005). Because TKO HSCs are
less quiescent than wild-type HSCs, we sought to test their re-
constitution properties. To this end, 106 control or Mx1-Cre
TKO BM cells expressing the Ly5.1 surface marker were trans-
planted together with 106 Ly5.1/Ly5.2 wild-type competitor cells
into lethally irradiated Ly5.2 Rag2/commongchain double mu-
tant immunodeficient mice. Four weeks after transplantation,leukocyte chimerism was assessed in the PB. As shown in
Figure 5A, Mx1-Cre TKO cells outcompeted control competitor
cells in this short-term reconstitution setting. As expected given
the expansion of these cells in TKO mice, this advantage was
more pronounced in myeloid populations (Figure 5B). Strikingly,
however, all the recipients ofMx1-Cre TKO cells died by week 5,
while recipients of control cells survived (n = 5). Because irradi-
ated mice that were not transplanted with any cells died
2 weeks after irradiation (data not shown), the death of mice
reconstituted with TKO cells after 5 weeks suggested that TKO
hematopoietic progenitors were only transiently able to reconsti-
tute the hematopoietic system of recipient mice. Consistent with
this idea, the BM cellularity was reduced in recipients of TKO
cells compared to controls (Figure 5C). Despite this overall
decreased cellularity, a majority of the mature hematopoietic
cells were TKO and not wild-type competitors (Figure 5D).
Importantly, hematopoietic progenitor cell numbers, including
LT-HSCs, were significantly decreased in the BM of mice
reconstituted with TKO cells (Figure 5E).
Taken together, these results suggest that TKO early hemato-
poietic progenitors are very efficient at short-term repopulation,
outcompeting wild-type cells and preventing their engraftment,
probably by producing an outburst of myeloid cells. This obser-
vation may in part reflect the increased numbers of TKOKLS and
mature myeloid cells transplanted as well as the hyperprolifera-
tive status of early progenitors. Nevertheless, hyperproliferative
TKO HSCs are severely impaired in their long-term
reconstitution potential in vivo, as illustrated by the decrease of
LT- and ST-HSC populations and the rapid death of the trans-
planted recipients. This inability of TKO HSCs to reconstitute
the blood systemmay have several nonexclusive causes, includ-
ing, but not limited to, a reduced homing potential, an increased
mobilization and an incapacity to stably reside in the BM that
may be due to their hyperproliferative status, and a loss of self-
renewal upon the stress of the transplantation.
The Myeloproliferation Present in TKO Mice Arises
Quickly and Is Transplantable
To further determine the kinetics and the cell autonomy of the
TKO phenotype, we sought to investigate if these defects arose
both rapidly and in transplanted mice. Low leaky expression of
theMx1 promoter in the absence of pI-pC injections and expres-
sion of this promoter in many cell types upon induction (data not
shown) (Kuhn et al., 1995) precluded the use of theMx1Cre TKO
model for this purpose. To bypass this problem, we crossed
condTKO mice to Rosa26Cre-ERT2 mice (Ventura et al., 2007).
In these mice, Cre expression is very broad, but its activity is
strictly dependent on tamoxifen injection (data not shown).
Rosa26Cre-ERT2 TKO mice died on average 2–3 weeks after
tamoxifen injection due to efficient deletion of the Rb and p130
alleles and loss of the entire Rb family in multiple cell types, in-
cluding BM cells (Figure 6A and data not shown). Rosa26Cre-
ERT2 TKO mice may die from digestive defects, as they show
a rapid weight loss, but at these early time points, the spleen,
thymus, and liver of mutant mice displayed normal appearance
(data not shown).
Two weeks after Cre induction, KLS, MP, and GMP cell num-
bers remained similar to control numbers in the BM of Rosa26-
Cre-ERT2 TKO mice. However, both CMP and CLP populationsCell Stem Cell 3, 416–428, October 9, 2008 ª2008 Elsevier Inc. 419
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Rb Family Inactivation in Hematopoietic Stem CellsFigure 3. Reintroduction of One Wild-Type Allele of p107 Rescues the TKO Myeloproliferative Phenotype
(A) Cytospins on unfractioned BM from control and Mx1-Cre p107-Single mice show a similar cellular composition 6 months after pI-pC treatment.
(B) FACS analysis of BM progenitor cells in control (CT) and p107-Single mice.
(C and D) Analysis of mature myeloid (Mac-1/Gr-1) and B cell (B220) populations in the BM (C) and spleen (D) of control and p107-Single mice.
(E) Analysis of DNA content (PI) of control and p107-Single KLS cells (n = 3; p value, ns).were already significantly decreased in Rosa26Cre-ERT2 TKO
mice (Figure 6B and Figure S4A). In addition, analysis of mature
BM cells already showed a significant increase in the pre-M pop-
ulation and a decrease in the B cell lineage (Figure 6C and Fig-
ure S4B). Thus, the shift toward the myeloid lineage is very rapid
in TKO mice.
To further probe the mechanisms underlying this phenotype,
we tested the apoptotic activity in control and TKO hematopoi-
etic stem/progenitor cells using Annexin V staining. We found
that the number of apoptotic KLS and MP TKO cells was low
but that TKO CLP cells displayed a significant increase in cell
death compared to controls (Figure 6D), suggesting that en-
hanced death is one mechanism leading to decreased numbers
of lymphoid cells in TKO mice.Increased proliferation was also observed in the BM of
Rosa26Cre-ERT2 TKO mice 2 weeks after Cre induction, most
strikingly in the KLS population, which exhibited a high replicative
rate (Figures 6E). Both TKO CMP and GMP populations showed
an increased proliferation (Figure 6F). Control experiments
showed that loss of p130 only in induced Rosa26Cre-ERT2
p130lox/lox mice did not affect the proliferation of KLS cells, while
the acute loss of Rb had only a mild effect (Figure 6G). The fact
that no cell-cycle defect was observed inRb-deficient KLS popu-
lations in longer-term experiments (Daria et al., 2008;Walkley and
Orkin, 2006; Walkley et al., 2007) is again suggestive of compen-
satory mechanisms similar to what was observed in mouse fibro-
blasts (Sageetal., 2003). This result further underscores theextent
of the functional overlapwithin theRbgene family. Together, theseFigure 2. Increased Proliferative Potential and Altered Fate of Rb Family TKO Early Hematopoietic Progenitor Cells
(A) Proliferation analysis of sorted pre-M cells, MP, and KLS cells (n > 3).
(B) Analysis of MP and KLS populations in control and TKO mice 2 months after pI-pC treatment.
(C) Total number of KLS cells, Flk2 cells, and Flk2+ cells in the BM of control and TKO mice (pooled from the four limbs) (n = 5).
(D) Total number of MP, CMP, GMP, and MEP in the BM (four limbs) (n = 5).
(E) Analysis of the CLP population.
(F) Total number of CLP cells (n = 5).
(G) Proliferation analysis of CD34+/CD34 KLS cells and CMP/GMP cells (n = 3).
(H) Methylcellulose assay with 10,000 unfractioned BM cells, 100 sorted KLS cells, and 100 double-sorted MP cells. Data are mean ± SD.
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Rb Family Inactivation in Hematopoietic Stem CellsFigure 4. TKO Hematopoietic Progenitors Cells Are Mobilized and Less Capable to Home Back to the BM
(A) Analysis of myeloid progenitors (MP) and KLS cells in the spleen of control and TKO mice 2 months after pI-pC treatment.
(B) Total number of stem/progenitor cells in the spleen of control and Mx1-Cre TKO mice (n = 5).
(C) Total number of KLS subpopulations (LT-HSC, ST-HSC, and MPP) in the spleen of control and mutant mice (n = 5).
(D) Methylcellulose assay with 50,000 control and TKO unfractioned splenocytes.
(E) Analysis of MP and KLS cells in the PB of control and Mx1-Cre TKO mice.
(F) Homing assays. 23 106 control (n = 9) orMx1-Cre TKO (n = 10) Lineageneg cells were labeled with CFSE and transplanted into immunodeficient mice. Sixteen
hours later, mice were sacrificed and their BM analyzed for the presence of fluorescent CFSE+ cells. Data are mean ± SD.results show that loss of Rb family genes rapidly induces the pro-
liferation of hematopoietic progenitors and initiates a myeloprolif-
eration similar to that observed in agedMx1-Cre TKO mice.
To explore a possible role for the microenvironment in the de-
velopment of the TKO phenotype, we transplanted wild-type
Ly5.1/Ly5.2 BM cells into lethally irradiated Ly5.1 control and
Rosa26Cre-ERT2 condTKOmice. Following establishment of he-
matopoiesis, mice were treated with tamoxifen, thereby deleting
Rb family genes in multiple cell types, except donor HSCs and
their progeny. As expected, TKO-recipient mice died approxi-
mately 2–3 weeks after induction, while control mice remained
healthy. Analysis of the progenitor compartment did not reveal
422 Cell Stem Cell 3, 416–428, October 9, 2008 ª2008 Elsevier Inc.significant changes between control and TKO populations
(Figure S4C). In addition, wild-type donor cells transplanted
into TKO recipients did not show a significant increase in the
pre-M population (Figure S4D).
To further investigate the cell-intrinsic nature of the TKO phe-
notypes, we then tested the ability of Rosa26Cre-ERT2 TKO BM
cells to recapitulate the disease when Cre-mediated recombina-
tion occurred after transplantation in wild-type recipient mice. To
this end, we transplanted 4 3 106 unfractioned control or
Rosa26Cre-ERT2 condTKO BM cells into sublethally irradiated
(1.5G) SCID mice and injected these recipient mice with tamox-
ifen 5 days after transplantation. Within 4 weeks, all recipients of
Cell Stem Cell
Rb Family Inactivation in Hematopoietic Stem CellsRosa26Cre-ERT2 TKO cells displayed an expansion of pre-M
myeloid cells (n = 4) (Figure 6H).
Similarly, longer-termexperiments showed that, 4monthsafter
induction of Cre, lethally irradiated immunodeficient Rag2/
mice transplantedwithRosa26Cre-ERT2 TKOBMcells displayed
amyeloproliferation phenotype with infiltration of myeloid cells in
the skin and the liver and enlargement of the spleen and disrup-
tion of its normal architecture (Figures S5A–S5H). Accordingly,
FACS analysis indicated that the mice with mutant blood cells
had increased numbers of pre-M cells and decreased numbers
of B cells (Figures S5I and S5J). Cell-cycle analysis of TKO KLS
and MP populations showed a reproducible increase in the pro-
liferativestatusof thesecells compared tocontrol cells (Figure6I).
Taken together, these results demonstrate that the hyperpro-
liferative phenotype of TKO hematopoietic progenitors and the
myeloproliferation associated with Rb family deficiency are pri-
marily cell autonomous.
Rb Family Mutant Early Hematopoietic Progenitors Are
Aberrantly Primed to Produce Myeloid Cells
Given the broad role of pRB family proteins as transcriptional
modulators,we assessed themolecular basis of the TKOmyeloid
disease by gene expression profiling. A first analysis revealed
that the gene programs affected by loss of Rb family genes in
KLS cells were significantly similar to those affected by loss of
Rb alone in early erythroid progenitors (Sankaran et al., 2008) (p
< 23 105 and p < 23 104 for upregulated and downregulated
genes, respectively), although the fold changes were generally
greater in TKO cells (data not shown). These observations vali-
date the presence of an ‘‘Rbmutant’’ signature in TKO KLS cells.
Figure 5. The Long-Term Reconstitution
Potential of TKO HSCs Is Impaired
(A) Chimerism of PB from Rag2/commongchain
deficient Ly5.2mice 4 weeks after lethal irradiation
and transplantation of 106 unfractioned control
(left, white) or Mx1-Cre TKO (right, black) Ly5.1
BM cells together with 106 Ly5.1/Ly5.2 competitor
wild-type cells (WT, gray) (n = 3 mice analyzed for
a total of 5mice transplanted and displaying a sim-
ilar phenotype) (same transplantation conditions
for all the experiments below).
(B) PB chimerism of B cell (B, B220+) and myeloid
cell (M, Mac-1+) populations 4 weeks after trans-
plantation.
(C) Total BM cellularity from the two lower limbs of
recipient mice 5 weeks after transplantation.
(D) BM chimerism for myeloid or B cell populations
and unfractioned hematopoietic population
5 weeks after transplantation.
(E) Total cell number of KLS, MPP, ST-HSC, and
LT-HSC subpopulations 5 weeks after transplan-
tation (lower limbs). Data are mean ± SD.
Assignment of differentially expressed
genes to functional annotation groups
further revealed that a significant number
of genes associated with cell-cycle pro-
gression were upregulated in TKO cells
when compared to control cells, including
members of the E2f gene family and
genes coding for structural components of mitotic chromo-
somes (Figure 7A). These data are consistent with the hyperpro-
liferative status of the mutant cells.
We also found that many genes belonging to mature lymphoid
cell annotation groups, such as genes coding for immunoglobu-
lins and major histocompatibility class (MHC) II molecules, were
downregulated in TKO KLS cells (Figure 7B). In addition, the
expression of known regulators of lymphoid development, in-
cluding the Lck, Rag1, and IL7R genes, was also decreased
(Figure 7B). Conversely, genes coding for Gm-csfr and the
Gata-2 transcription factor, two critical promoters of myeloid
development, were upregulated in TKO KLS cells (Figure 7C).
Gata-2 overexpression in KLS cells is sufficient to direct their
differentiation toward eosinophils (Hirasawa et al., 2002). Real-
time q-RT-PCR analysis confirmed that expression of Gata-2 is
significantly increased in purified KLS cells (Figure 7C). We
also found that several genes that code for markers of the
neutrophil lineage were downregulated in TKO KLS cells
(Figure 7C). Together, these gene expression data strongly cor-
relate with the hematopoietic phenotype of TKO mice and indi-
cate that gene programs that are altered upon loss of Rb family
genes in KLS cells may prime these early hematopoietic progen-
itors to generate a myeloproliferation characterized by the ex-
pansion of an eosinophilic population (Figure 7D).
DISCUSSION
Here we report the in vivo phenotype of adult mouse hematopoi-
etic cells with compound genetic inactivation of Rb, p107, and
p130. Loss of the entire Rb gene family induces loss of HSC
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accompanied by extramedullary hematopoiesis, and a large ex-
pansion of eosinophilic granulocytes. These results underscore
the role of pRB, p107, and p130 in stem and progenitor cells
and provide a cellular mechanism by which loss of RB family
functions may initiate cancer in humans.
Figure 6. Loss of Rb Family of Genes Induces Rapid and Cell-Intrinsic Defects in Hematopoietic Progenitors
(A) Efficient recombination of Rb and p130 alleles in the BM of Rosa26-CreERT2 TKO mice 2 weeks after tamoxifen treatment as shown by real-time q-RT-PCR
(n = 3).
(B) Number of progenitors/million of BM cells in control and TKO mice (n = 5).
(C) Cellularity of pre-M and B cells in the BM (two limbs) (n = 5).
(D) Apoptotic activity in stem/progenitor cells. Cells from control or Rosa26-CreERT2 TKO mice were stained with Annexin V 2 weeks after tamoxifen treatment
(n = 3).
(E and F) Proliferation analysis of MP and KLS cells (E) and CMP and GMP cells (F) from the BM of control and Rosa26-CreERT2 TKO mice (n = 3).
(G) Proliferation activity of KLS cells from either control, Rosa26-CreERT2 Rblox/lox, Rosa26-CreERT2 p130lox/loxox, or Rosa26-CreERT2 TKO mice 2 weeks after
tamoxifen treatment.
(H) Analysis of the BM of SCIDmice transplanted with 43 106 unfractioned BM cells from control and Rosa26-CreERT2 TKO mice (analysis performed 4 weeks
after tamoxifen treatment) (n = 4).
(I) Representative (n = 2) cell-cycle profile of purified KLS and MP populations in Rag2 mutant mice lethally irradiated and transplanted with control or Rosa26-
CreERT2 TKO cells and aged 4 months after induction of Cre (see Figure S5 for experimental details). Data are mean ± SD.
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Rb Family Inactivation in Hematopoietic Stem CellsFigure 7. The TKO Myeloproliferation Phenotype Is Primed by Altered Gene Expression Programs in Rb Family Mutant KLS Cells
(A) Cell-cycle-associated genes are upregulated in TKO KLS cells. The heat map shows the expression of genes with cell-cycle-related functional annotations
that are significantly upregulated in Rb family mutant KLS cells. The rows correspond to genes and the columns to samples. Gene expression values (relative
to the mean expression in control cells) are indicated on a log2 scale according to a color scheme shown, in which yellow and blue represent up- and
downregulation, respectively. The Venn diagram shows the overlap between genes upregulated in these cells and genes associated with the Gene Ontology
(GO) Biological Process term ‘‘cell cycle.’’ Genes lacking any GO Biological Process annotation were excluded from this analysis. This overlap is greater
than expected for unrelated categories of these sizes, as indicated by the Benjamini-Hochberg corrected p value calculated using a modified Fisher’s exact
test.
(B) Genes associated with lymphoid development are downregulated in TKO KLS cells.
(C) The genes encoding two regulators of myeloid differentiation (GM-CSFR and GATA2) are upregulated in TKO KLS cells. In addition, certain genes
associated with neutrophil development are downregulated. The changes in Gata-2 expression were confirmed by real-time q-RT-PCR (n = 3).
(D) Hematopoietic lineage tree showing the impact of the genetic ablation of Rb, p107, and p130 in mouse HSCs and their progeny.
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of Quiescence and Mobilization
and Impaired Transplantation
We found that loss of all Rb family genes activates the prolifera-
tion and increases the total numbers of mouse HSCs. The RNA
levels for genes involved in the self-renewal of stem cells (e.g.,
Bmi1, Hoxb4, and Hes1) did not reveal any differences between
TKO and control KLS cells (Figure S6). When serially replated in
methylcellulose, KLS cells from control and Mx1-Cre TKO mice
both replated each three times (data not shown). Together, these
observations suggest that TKO HSCs do not have a major self-
renewal defect. However, TKO mutant mice become rapidly
sick and cannot be aged to study the fate of TKO HSCs in the
long-term. In addition, TKOHSCs fail to stably reconstitute a sta-
ble hematopoietic system in transplantation experiments. Thus,
it is possible that, under certain stress conditions, loss of the en-
tireRb gene familymay affect the self-renewal potential of HSCs.
Increased proliferation is often associated with loss of self-
renewal in HSCs, and alterations in some upstream regulators
of the RB pathway and other key cell-cycle inhibitors such as
PTEN and FoxOs have been associated with self-renewal
defects (Tothova et al., 2007; Zhang et al., 2006). However,
increased proliferation in HSCs without loss of self-renewal has
been observed in p18Ink4c-deficient mice (Yu et al., 2006), and
it has been proposed that mutations in genes controlling the
early G1 phase of the cell cycle—such as p18Ink4c and Rb family
genes—in quiescent stem cells may result in increased prolifer-
ation with no effects on the self-renewal (Orford and Scadden,
2008). More studies are clearly required to better comprehend
the molecular links between cell cycle and self-renewal potential
in HSCs and other stem cells, including cell-autonomous and
non-cell-autonomous aspects (Zon, 2008).
Increased proliferation of HSCs has also been linked to an
inability to transplant, although the molecular mechanisms un-
derlying this observation are still largely unknown (Passegue
et al., 2005). It is not clear if the mobilization, decreased homing
potential, and overall incapacity to transplant of TKO HSCs are
only direct consequences of their hyperproliferative status or if
other cellular functions are altered in these mutant cells. Future
experiments with Rb family mutant mice and other mutants will
help to explore themechanisms by which HSCs can reconstitute
the blood system upon transplantation.
Loss of Rb Family Genes in HSCs Results
in the Expansion of Myeloid Progenitors
and a Cell-Autonomous Myeloproliferation
The rapidity of development of the TKO myeloproliferation and
its recapitulation in transplanted animals show that it is largely
an intrinsic consequence of loss of Rb family genes in hemato-
poietic cells. Rb-only mutant mice display a mild neutrophilic
myelodysplasia that is largely induced by the BM microenviron-
ment (Spike et al., 2004; Walkley et al., 2007). p107mutant mice
in a Balb/c genetic background also develop a mild myeloid
hyperplasia (LeCouter et al., 1998). Together, these observations
directly implicate the Rb gene family in restricting myeloid cell
expansion in vivo.
Interestingly, the TKO myeloproliferation does not come from
an increased proliferation of mature myeloid cells but rather orig-
inates from altered gene programs and cell-fate decisions in
426 Cell Stem Cell 3, 416–428, October 9, 2008 ª2008 Elsevier Inc.early hematopoietic progenitors. These data also suggest that
loss of Rb family genes is not sufficient to prevent cell-cycle
arrest in some differentiating hematopoietic populations, a
phenomenon that will require additional studies in other cell
lineages in vivo.
TKO mice display a decrease in lymphoid progenitors and B
cell populations, a phenotype likely due to increased cell death
in CLP populations and decreased expression of a program of
genes that normally prime KLS cells to generate lymphoid cells,
similar to what has been described for aging hematopoietic
progenitors (Rossi et al., 2008).
Importance of p130 and p107 in the Regulation
of HSCs and Hematopoiesis
Several recent reports have characterized the consequences of
loss of Rb only in hematopoiesis (Daria et al., 2008; Spike et al.,
2004;Walkley and Orkin, 2006;Walkley et al., 2007). These stud-
ies and our own characterization of Rb mutant mice all show an
increased mobilization of Rb mutant hematopoietic progenitors
accompanied by extramedullary hematopoiesis. These data
indicate that p107 and p130 do not always functionally compen-
sate for loss of pRB. However, TKO mice have many different
phenotypes compared to Rb mutant mice. While Rb mutant
mice develop a neutrophilic myeloproliferation, TKO mice de-
velop an eosinophilic disease. Walkley et al. clearly showed
that the neutrophilic expansion in Rb mutant mice has a strong
non-cell-autonomous component. In contrast, the TKO eosino-
philic expansion is largely cell intrinsic. TKO mice might eventu-
ally also develop a neutrophilic defect in the absence of the rapid
eosinophilic disease. Alternatively, loss of Rb, p107, and p130
may reprogram MPs to produce eosinophils specifically. In
both cases, the additional loss of p107 and p130 generates
a novel phenotype.
Our data also indicate that the TKOmyeloproliferation is driven
by the KLS compartment, while the origin of the defect is still
unclear in Rb-deficient mice, as the Lyz-M Cre model used by
Walkley et al. is mostly expressed in mature myeloid cells but
also in a subset of early progenitors (Ye et al., 2003).
But the most striking difference between the TKO and Rb
mutant models lies in the HSC phenotype. Rb mutant HSCs
are not continually hyperproliferative, highlighting the compen-
satory role of p130 and p107 in controlling the cell cycle of these
stem cells. TKOs, but not Rb/ HSCs, have impaired homing
activity and fail to transplant (Daria et al., 2008; Walkley et al.,
2007). These observations suggest that mobilization of hemato-
poietic progenitors out of the BM and homing back to the BM
may be controlled by different mechanisms but that both
processes are regulated by the three members of the Rb gene
family.
Together, our results indicate that p107 and p130, in addition
to pRB, have essential functions during hematopoiesis, including
in HSCs. These compensatory roles between pRB, p107, and
p130 may also explain why human blood malignancies often
have alterations in upstream regulators of the entire pRB family
(Barista et al., 2001; Leoncini et al., 2006; Maru, 2001; Mihara
et al., 2006; Spike and Macleod, 2005; and references included).
This analysis of the phenotype of Rb family TKO HSCs and
hematopoietic progenitors complements recent in vivo studies
with mice mutant for families of mammalian genes, especially
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Rb Family Inactivation in Hematopoietic Stem Cellscell-cycle regulators (Geng et al., 2003; Kozar et al., 2004; Krim-
penfort et al., 2007; Santamaria et al., 2007). Future experiments
will continue to investigate the role of Rb family genes in the
control of cell-cycle re-entry in quiescent and differentiated cells
to probe the cellular mechanisms of cancer initiation.
EXPERIMENTAL PROCEDURES
Mice
Rb family conditional TKO mice were obtained by crossing Rb conditional
mutant mice (Sage et al., 2003) with p107/ mice (Lee et al., 1996) and
p130 conditional mutant mice (to be described elsewhere) in a mixed 129Sv/
J and C57/BL6 background.
Induction of Cre in Mx1-Cre mice (Kuhn et al., 1995) was performed by five
consecutive daily injections of 200 mg of pI-pC (Sigma P-0913). In Rosa26-
CreERT2 TKO mice, Cre was induced by five consecutive injections of 1 mg
of tamoxifen (Sigma T-5648) in corn oil. Inductions were performed on
6-week-old mice.
Ly5.2-expressing Rag2/Commong chain double KO mice were obtained
from the Weissman laboratory at Stanford. SCID and Rag2 mutant mice
were purchased from Stanford’s Research Animal Facility.
All the experiments with mice were approved by Stanford IACUC (protocol
13565).
Flow Cytometry
Cells from the BM, spleen, and PBwere filtered, and red blood cells were lysed
with the ACK buffer (NH4Cl/KHCO3). Mature white blood cells (WBCs) were
subsequently stained with antibodies against B220, Mac-1, Gr-1, and
Ter119 for 30 min. Progenitor cells were stained with a cocktail of lineage-
cy5PE antibodies and subsequently stained with antibodies against c-Kit,
Sca1, Flk2, CD34, FcgR, or Il7Ra. All the antibodies were purchased from
eBioscience. All analysis was performed at the Stanford FACS Facility on
FacsScan or LSR by using the CellQuest software for data acquisition. Data
were analyzed using the FlowJo software (Tree Star). Experiments displayed
are representative of three or more independent experiments. To sort progen-
itor cells, WBCs were first incubated with c-Kit beads (Miltenyi Biotech) and
purified on columns (Automacs, Miltenyi Biotech). The c-Kit-enriched fraction
was subsequently stained with lineage, c-Kit, CD34, Flk2, and Sca1 anti-
bodies. Cells were sorted on a Vantage machine.
Cell Proliferation and Cell Death Assays
Mice were injected with BrdU 1 hr before sacrifice. Unfractioned BM cells or
sorted subpopulations were fixed in 70% ethanol overnight and stained with
an anti-BrdU antibody (BD) and propidium iodide (PI) as described before
(Passegue et al., 2005). Cell survival was analyzed by Annexin V staining
(Roche).
Methylcellulose Assays, Cytospin, and Cellular Blood Counts
Unfractioned splenocytes (50,000) or BM cells (20,000), KLS (100), MPs (100)
or mature Mac-1+/Gr-1Low (10,000) cells were plated in Methocult M3434 from
Stem Cell Technologies. Colonies were evaluated 8–10 days after plating.
Replating was performed with 20,000 cells. Every experiment was performed
independently three times in duplicate. For cytospin analysis, 20,000 cells
were centrifuged onto a glass slide. Slides were then stained with Giemsa
(Fisher Scientific).
Transplantation and Homing Assays
As a result of their 129Sv/J:C57BL/6mixed genetic background, Ly5.1WT and
Mx1Cre TKO cells could not be transplanted in F1 mice generated by breeding
Ly5.1 WT and Ly5.2 C57BL/6 mice. To circumvent this caveat, we trans-
planted unfractioned BM cells (2 or 4 million) into SCID or Rag2/commong
chainKO immunodeficient mice. Prior to transplantation,SCIDmicewere sub-
lethally irradiated with 1.5 G, while Rag2/commongchainmutants were lethally
irradiated with 9G. We successfully transplanted Ly5.1/Ly5.2 F1 BM cells into
Ly5.1 control and Rosa26-CreERT2 TKO mice. Prior to transplantation, recip-
ient mice were lethally irradiated with 9G and allowed to recover overnight.
Mice were fed with antibiotics for 3 weeks, and the transplantation efficiencywas monitored after 4 weeks by analyzing Ly5.1/Ly5.2 expression in the PB.
Transplantations were performed retro-orbitally in anesthetized mice.
For homing experiments, we isolated lineage-negative cells by staining
WBCs fromBMwith unconjugated lineage antibodies (raised in rat). Next, cells
were incubated with antirat beads and subsequently run on an Automacs
(Miltenyi). Positively selected cells were stained with a fluorescent dye
(CFSE, Invitrogen) for 30 min in the dark. An aliquot of the cells was analyzed
by FACS to confirm appropriate staining. 23 106 cells were injected into SCID
mice, and recipient mice were sacrificed 16 hr later. The BM was flushed sep-
arately from each lower limb, and CFSE+WBCs from each limb were analyzed.
Real-Time q-RT-PCR and Microarray Analysis
RNA was processed and PCR reactions were prepared as described before
(Passegue et al., 2005). Primer sequences are available upon request. A total
of 10,000 KLS cells from either control or Mx1-Cre TKO were used for micro-
array analysis. Samples processing and data analysis are described in the
Supplemental Experimental Procedures.
Statistics
Statistical significance was assayed by Student’s t test; *p < 0.05; **p < 0.01;
***p < 0.005; ns, not significant.
SUPPLEMENTAL DATA
The Supplemental Data include six figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found with this article online
at http://www.cellstemcell.com/cgi/content/full/3/4/416/DC1/.
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